Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]

Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]

Gao J, Iwamoto H, Koskela J, et al. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11: 2457–2465. On page 2457, Abstract, line 3, the text “To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxida...

Full description

Bibliographic Details
Main Authors: Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, Pulkkinen V
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:International Journal of COPD
Online Access:https://www.dovepress.com/erratum-httpswwwdovepresscomcharacterization-of-sputum-biom-peer-reviewed-article-COPD
Description
Summary:Gao J, Iwamoto H, Koskela J, et al. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11: 2457–2465. On page 2457, Abstract, line 3, the text “To clarify the inflammatory mediatypical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected” should be “To clarify the inflammatory mediators typical for ACOS, five biomarkers, namely interleukin (IL)-13, myeloperoxidase (MPO), neutrophil gelatinase-associated lipocalin (NGAL), chitinase-like protein (YKL-40), and IL-6, were selected.” Read the original article
ISSN:1178-2005

Similar Items